First American Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.78M Sell
99,392
-36,858
-27% -$2.97M 0.47% 65
2026
Q1
$11.8M Buy
136,250
+10,926
+9% +$1.05M 0.79% 35
2025
Q4
$12M Buy
125,324
+24,399
+24% +$2.37M 0.83% 33
2025
Q3
$9.61M Buy
100,925
+1,306
+1% +$120K 0.7% 42
2025
Q2
$8.68M Buy
99,619
+772
+0.8% +$65.5K 0.69% 45
2025
Q1
$8.88M Buy
98,847
+34,921
+55% +$3.12M 0.82% 37
2024
Q4
$5.11M Buy
+63,926
New +$5.53M 0.51% 65

Other funds holding MDT

First American Trust's MDT Position: Q2 2026 in Review

First American Trust reduced its Medtronic (MDT) stake by 27% in Q2 2026, selling an estimated $2.97M and leaving 99,392 shares worth $7.78M. The position accounts for 0.47% of the portfolio, ranked #65.

First American Trust first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $12M in Q4 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • First American Trust held 99,392 shares of Medtronic worth $7.78M as of Q2 2026.
  • First American Trust sold 36,858 Medtronic shares in Q2 2026, an estimated $2.97M.
  • Medtronic made up 0.47% of First American Trust's portfolio in Q2 2026, its #65 holding.
  • First American Trust first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • First American Trust's Medtronic position peaked at $12M in Q4 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on First American Trust's 13F filing for Q2 2026, filed 10 Aug 2026.